Eli Lilly (LLY) stock slips as IQVIA data show that the company's obesity drugs Zepbound and Foundayo lag Novo’s (NVO) Wegovy ...
Some patients are being forced off their GLP-1 medication after losing insurance coverage. (NPR) Meanwhile, the Centers for ...
Wednesday, April 29, 2026 at 9 a.m. ET. CALL PARTICIPANTS. Chairman, President, and Chief Executive Officer — R. Trauschke; Senior Vice President and Chief Financial Offic ...
Foundayo was approved in the U.S. on April 1, with prescriptions accepted immediately on LillyDirect, while shipping started ...
Royal Challengers Bengaluru crushed Delhi Capitals in IPL 2026, highlighted by Suyash Sharma’s historic spell of 20 dot balls ...
The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit ...
Good day, and welcome to Ionis' First Quarter 2026 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the over to Wade Walke, Senior Vice ...
Site-neutral payment has advanced from E&M to drug administration codes, but stakeholders warn rapid, simultaneous policy ...
SoFi Technologies (NASDAQ: SOFI | SOFI Price Prediction) reported Q1 2026 results before the open on April 29, 2026, beating ...
IPL is all about unearthing new talent, especially homegrown players, and giving them a platform to showcase their ability. And both Praful Hinge and Sakib Hussain have scripted a memorable debut ...
Amazon (NASDAQ: AMZN) just made a quiet move that could reshape how Americans access weight-loss drugs. On April 9, 2026, it announced that its pharmacy unit will stock new GLP-1 weight-loss pill ...
Investor's Business Daily on MSN
Battle of the weight-loss pills continues with a shocking twist
Eli Lilly stock skidded early Friday as Novo Nordisk's oral Wegovy continued to outpace Lilly's new weight-loss pill, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results